Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers

• CinCor Pharma, Inc. CINC shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
• Apexigen, Inc. APGN jumped 111% to $1.99 after climbing more than 10% on Friday.
• Amryt Pharma plc AMYT gained 106.7% to $14.49 after Chiesi Farmaceutici announced it will acquire the company for $14.50 per ADS plus contingent value rights of up to an additional $2.50 per ADS.
• Albireo Pharma, Inc. ALBO shares climbed 92.9% to $44.03 after Ipsen announced it will acquire the company for $42 per share plus a contingent value right of $10 per share.
• Duck Creek Technologies, Inc. DCT gained 47% to $19.10 after the company agreed to be acquired by Vista Equity Partners for $2.6 billion.
• Revance Therapeutics, Inc. RVNC surged 43% to $28.25 as the company reported the FDA acceptance Of supplemental Biologics License Application for DAXXIFY for injection for the treatment of cervical dystonia.
• Novo Integrated Sciences, Inc. NVOS rose 35.9% to $0.2052. Novo Integrated Sciences recently reported it entered an agreement to purchase 100% of shares of SWAG in exchange for $1.00.
• Sema4 Holdings Corp. SMFR gained 34% to $0.3299. Sema4 sees preliminary 2022 pro-forma revenues of $170 million to $173 million.
• Comera Life Sciences Holdings, Inc. CMRA gained 32% to $2.02. Comera Life Sciences 10% owner Charles Cherington bought a total of 743,243 shares at an average price of $1.23.
• Party City Holdco Inc. PRTY climbed 31.9% to $0.2363. Party City shares dropped 50% on Friday following a report suggesting the company has hired a restructuring advisor and plans a bankruptcy filing within weeks.
• Bed Bath & Beyond Inc. BBBY rose 30.9% to $1.7150. Bed Bath & Beyond shares dropped over 22% on Friday following a report indicating the company could file for bankruptcy in the coming weeks.
• CureVac N.V. CVAC shares rose 30.4% to $10.77. CureVac shares jumped over 29% on Friday after the company announced data on joint COVID-19 and flu mRNA vaccine development programs.
• ZyVersa Therapeutics, Inc. ZVSA jumped 28% to $2.06.
• Better Choice Company Inc. BTTR gained 28% to $0.7293.
• Hempacco Co., Inc. HPCO rose 28% to $1.19.
• Bit Digital, Inc. BTBT gained 28% to $0.9498. Bit Brother regained compliance with Nasdaq minimum bid price requirements for continued listing.
• Celyad Oncology SA CYAD jumped 25.1% to $0.7482. Celyad Oncology recently reported it has decided to discontinue the development of its remaining clinical program CYAD-211.
• Paya Holdings Inc. PAYA gained 24.5% to $9.70 after Nuvei entered into a definitive agreement to acquire the company for $9.75 per share in cash.
• LexinFintech Holdings Ltd. LX jumped 24.5% to $2.9892.
• Xos, Inc. XOS jumped 23.3% to $1.00.
• NanoString Technologies, Inc. NSTG surged 23.1% to $9.77. NanoString issued preliminary financial and operational highlights for Q4 and FY 2022.
• Greenidge Generation Holdings Inc. GREE gained 22.1% to $0.4780.
• Barfresh Food Group, Inc. BRFH gained 21.1% to $1.49.
• Grove Collaborative Holdings, Inc. GROV jumped 20.6% to $0.5790.
• Exact Sciences Corporation EXAS gained 20.5% to $56.85 after the company announced preliminary Q4 results.
• Tempo Automation Holdings, Inc. TMPO jumped 20% to $1.26.
• Kronos Bio, Inc. KRON jumped 19.7% to $2.06. Kronos Bio announced discovery collaboration with Genentech to advance novel therapies against transcriptional targets in oncology.
• Bitfarms Ltd. BITF gained 19.4% to $0.65.
• Guardion Health Sciences, Inc. GHSI jumped 19.4% to $7.10.
• Lufax Holding Ltd LU jumped 17.5% to $2.5400.
• Marathon Digital Holdings, Inc. MARA gained 15.5% to $4.7250. Jefferies downgraded Marathon Digital from Buy to Hold and announced a $4 price target.
• Coinbase Global, Inc. COIN rose 12.5% to $37.42. Jefferies initiated coverage on Coinbase Global with a Hold rating and announced a price target of $35.
• Riot Blockchain, Inc. RIOT gained 12% to $4.78. Wells Fargo maintained Riot Platforms with an Equal-Weight and lowered the price target from $6 to $5.
• Viracta Therapeutics, Inc. VIRX rose 10.3% to $1.81 after the company announced first clinical response in epstein-barr virus-positive (EBV+) solid tumor setting.
• Zillow Group, Inc. Z gained 8.7% to $39.01 after B of A Securities upgraded the stock from Underperform to Buy and raised its price target from $22 to $42.
• Tesla, Inc. TSLA jumped 8.3% to $122.44 amid vehicle price cuts in China and indications that wait times for some Chinese Model Y vehicles have increased.
• Snowflake Inc. SNOW rose 8% to $133.93. Piper Sandler maintained Snowflake with an Overweight and lowered the price target from $200 to $194.

Losers

• Calithera Biosciences, Inc. CALA shares dipped 80.1% to $0.72. Calithera Biosciences announced board approval of complete liquidation and dissolution.
• MultiMetaVerse Holdings Limited MMV fell 58.4% to $4.81 after jumping 82% on Friday.
• Moolec Science SA MLEC fell 41.3% to $11.30 after jumping 258% on Friday.
• Peak Bio, Inc. PKBO dropped 28.8% to $2.5910.
• Cutera, Inc. CUTR fell 23.4% to $30.97 after the company reported preliminary unaudited financial results for FY22. The company expects to report revenue in the range of $252 million to $253 million for FY22.
• AMTD Digital Inc. HKD dropped 20.6% to $18.20.
• Cerus Corporation CERS fell 20.5% to $3.0060. Cerus sees preliminary Q4 product revenues of $44 million, up 10% year over year.
• Golden Sun Education Group Limited GSUN declined 19.5% to $1.8060.
• Magic Empire Global Limited MEGL dropped 19.5% to $2.23.
• Arrowhead Pharmaceuticals, Inc. ARWR fell 18.6% to $30.41. Takeda Pharmaceutical Co and Arrowhead Pharmaceuticals announced topline results from the Phase 2 SEQUOIA study of fazirsiran (TAK-999/ARO-AAT) for liver disease associated with alpha-1 antitrypsin deficiency (AATD-LD).
• First Wave BioPharma, Inc. FWBI dropped 17% to $0.8720.
• Monte Rosa Therapeutics, Inc. GLUE declined 17% to $6.57. Monte Rosa Therapeutics outlined progress across portfolio of molecular glue degraders and key anticipated milestones for 2023.
• Arvinas, Inc. ARVN dropped 15.8% to $28.68. Arvinas said the company and Pfizer have proposed a modification to planned Veritac-3 Phase 3 study.
• Infobird Co., Ltd IFBD fell 14.8% to $0.7999.
• Harmony Biosciences Holdings, Inc. HRMY dropped 14.4% to $45.92. Harmony Biosciences named Jeffrey M. Dayno, MD as interim CEO and expands role of Jeff Aronin to executive chairman.
• BioCryst Pharmaceuticals, Inc. BCRX fell 11.2% to $10.50 after the company reported preliminary FY22 ORLADEYO net revenue results and issued FY23 ORLADEYO net revenue guidance.
• VYNE Therapeutics Inc. VYNE fell 9.3% to $0.2051 after jumping around 28% on Friday. VYNE Therapeutics, during November, posted a Q3 loss of $0.16 per share.
• Neptune Wellness Solutions Inc. NEPT fell 8.8% to $0.5901 after jumping around 35% on Friday. Neptune recently announced receipt of NASDAQ notification.
• Corbus Pharmaceuticals Holdings, Inc. CRBP shares fell 8% to $0.1334 after gaining over 10% on Friday.
• Macy's, Inc. M fell 7.7% to $20.42 after the company issued Q4 adjusted EPS and sales guidance.

Also Check This Out Bitcoin Tops This Key Level; Gala, Solana Among Top Gainers